Ziller Shelby G, Standage-Beier Carrie S, Okwor Uzoamaka E, McClelland D Jean, Bakhshi Bahar, Coletta Dawn K, Bea Jennifer W
Department of Epidemiology and Biostatistics, University of Arizona, Tucson, Arizona, USA.
School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona, USA.
Obesity (Silver Spring). 2025 Aug;33(8):1416-1431. doi: 10.1002/oby.24314. Epub 2025 Jul 13.
This systematic review evaluates the relationship between adiposity and incident colorectal cancer (CRC) risk.
MEDLINE, Scopus, Embase, CINAHL, and CENTRAL were searched for articles that met the following criteria: 1) assessed adiposity measures; 2) included incident data for any diagnosed malignant stage of CRC, colon cancer, or rectal cancer; and 3) studied adults aged older than 18 years. Articles were assessed for bias using the National Institutes of Health study quality assessment tools.
Fifteen articles across ten studies met the inclusion criteria. Three significant associations were positive, one was negative, and eleven were nonsignificant and positive. Measures varied based on the tool, and these four tools were used to gather body composition measures: bioelectrical impedance, computerized tomography, dual-energy x-ray absorptiometry, and ultrasound. The most used were total body fat mass and percent fat, along with abdominal visceral and subcutaneous adipose tissues. Overall, higher levels of adipose were positively associated with an increased risk of CRC. The strength of associations and significance varied by body composition variable, measurement technique, tumor location, and sex.
Standardization is needed to better elucidate the relation between CRC and adiposity to allow for comparisons across papers. Additionally, a balance among precision, accessibility, and cost of measurements must be struck.
本系统评价评估肥胖与结直肠癌(CRC)发病风险之间的关系。
检索MEDLINE、Scopus、Embase、CINAHL和CENTRAL数据库,查找符合以下标准的文章:1)评估肥胖测量指标;2)纳入任何诊断为恶性阶段的CRC、结肠癌或直肠癌的发病数据;3)研究年龄大于18岁的成年人。使用美国国立卫生研究院研究质量评估工具对文章进行偏倚评估。
十项研究中的十五篇文章符合纳入标准。三项显著关联为阳性,一项为阴性,十一项为非显著且阳性。测量指标因工具而异,使用了以下四种工具来收集身体成分测量数据:生物电阻抗、计算机断层扫描、双能X线吸收法和超声。最常用的是全身脂肪量和脂肪百分比,以及腹部内脏和皮下脂肪组织。总体而言,较高水平的脂肪与CRC风险增加呈正相关。关联强度和显著性因身体成分变量、测量技术、肿瘤位置和性别而异。
需要进行标准化以更好地阐明CRC与肥胖之间的关系,以便进行跨论文比较。此外,必须在测量的精度、可及性和成本之间取得平衡。